Ellison Institute’s new 80,000-square-feet, state-of-the-art building at the nexus of West L.A.’s Silicon Beach and life sciences community, opening summer 2019. Courtesy of Luzzato Co.
The Lawrence J. Ellison Institute for Transformative Medicine of USC (Ellison Institute) is proud to announce the launch of their Institute Members Program.
Drawing on the breadth and depth of USC’s community, the initial group of 10 Institute Members has worked extensively with Ellison Institute’s core faculty across a wide range of disciplines.
The new members are biophysicists, chemists, engineers, computer scientists, health economists, pathologists and physician-scientists who share founding Director and CEO Dr. David Agus’s bold vision for transforming cancer research and unbridled passion for championing patient-centered healthcare.
“The Founding Institute Members join me and my team during an exciting time. We are planning the move to our permanent home, growing our faculty and administrative leadership teams, and forging new collaborations. By working together, we will change the way we treat and prevent cancer,” Agus said.
The Founding Ellison Institute Members are (in alphabetical order):
The new members are biophysicists, chemists, engineers, computer scientists, health economists, pathologists and physician-scientists who share founding Director and CEO Dr. David Agus’s bold vision for transforming cancer research and unbridled passion for championing patient-centered healthcare.
“The Founding Institute Members join me and my team during an exciting time. We are planning the move to our permanent home, growing our faculty and administrative leadership teams, and forging new collaborations. By working together, we will change the way we treat and prevent cancer,” Agus said.
The Founding Ellison Institute Members are (in alphabetical order):
Andrea M. Armani, PhD
Stacey D. Finley, PhD
Scott E. Fraser, PhD
Dana P. Goldman, PhD
Carl F. Kesselman, PhD
Heinz-Josef Lenz, MD
Charles E. McKenna, PhD
Paul K. Newton, PhD
Michael F. Press, MD, PhD
Fei Sha, PhD
Stacey D. Finley, PhD
Scott E. Fraser, PhD
Dana P. Goldman, PhD
Carl F. Kesselman, PhD
Heinz-Josef Lenz, MD
Charles E. McKenna, PhD
Paul K. Newton, PhD
Michael F. Press, MD, PhD
Fei Sha, PhD
The Ellison Institute Members fulfill three major roles:
First, to lead change in biomedical and clinical research by collaborating with the Ellison Institute on high-impact, multidisciplinary, team-oriented science with the greatest promise for transforming human health.
Second, to advance the mission of the Ellison Institute by helping to engage additional world-renowned researchers, innovators and technologists in the Ellison Institute’s strategic research directions.
Third, to provide counsel about strategic research programs and help advance science through high-impact collaborations, including academic-industry partnerships.
“The Ellison Institute offers extraordinary opportunities to collaborate and reimagine research and clinical care for patients in the modern era of molecular-driven medicine. I am thrilled to formally add these long-time collaborators with the launch of the Institute Members Program and I look forward to furthering our efforts with them and others as the Institute continues to grow,” said professor Jerry S.H. Lee, the Institute’s chief science and innovation officer.
First, to lead change in biomedical and clinical research by collaborating with the Ellison Institute on high-impact, multidisciplinary, team-oriented science with the greatest promise for transforming human health.
Second, to advance the mission of the Ellison Institute by helping to engage additional world-renowned researchers, innovators and technologists in the Ellison Institute’s strategic research directions.
Third, to provide counsel about strategic research programs and help advance science through high-impact collaborations, including academic-industry partnerships.
“The Ellison Institute offers extraordinary opportunities to collaborate and reimagine research and clinical care for patients in the modern era of molecular-driven medicine. I am thrilled to formally add these long-time collaborators with the launch of the Institute Members Program and I look forward to furthering our efforts with them and others as the Institute continues to grow,” said professor Jerry S.H. Lee, the Institute’s chief science and innovation officer.